Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/4/2025

PPI Treatment Duration for Grade B Esophagitis in Patients on DOACs

Initial Treatment Phase

  • The American College of Gastroenterology recommends standard-dose PPI therapy for 8 weeks for patients with Grade B erosive esophagitis, as this condition constitutes conclusive GERD requiring continuous acid suppression 1, 2
  • PPIs should be taken 30-60 minutes before meals for optimal acid suppression, according to the American Gastroenterological Association 2
  • Grade B esophagitis represents conclusive GERD evidence requiring definitive treatment, as stated by the American College of Gastroenterology 1

Rationale for 8-Week Initial Course

  • The American College of Gastroenterology recommends an 8-week initial course of PPI therapy, as this duration aligns with guideline recommendations for assessment of treatment response 1, 3

Maintenance Therapy Requirements

  • Patients with Grade B erosive esophagitis require continuous long-term maintenance PPI therapy, rather than on-demand therapy, as this represents more severe GERD with documented mucosal injury, according to the American College of Gastroenterology 2
  • Step down to the lowest effective dose that maintains symptom control and mucosal healing, as recommended by the American Gastroenterological Association 2, 3
  • Grade B esophagitis constitutes a definitive indication for long-term PPI use and should generally not be considered for PPI discontinuation, as stated by the American College of Gastroenterology 2
  • Periodic reassessment of the need for continued therapy is recommended, but most patients will require indefinite treatment, according to the American Gastroenterological Association 2, 4

Special Considerations for DOAC Use

  • The concurrent use of DOACs does not alter PPI treatment duration or dosing for Grade B esophagitis, but PPIs provide gastroprotection in patients on anticoagulation who are at increased risk for GI bleeding, as stated by the American College of Gastroenterology 2
  • The presence of anticoagulation therapy reinforces the importance of maintaining complete mucosal healing to prevent bleeding complications, according to the American Gastroenterological Association 4

Treatment Algorithm

  • The American College of Gastroenterology recommends the following treatment algorithm: